Avnur Zafrira 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Jun 19, 2018
Insider Transaction Report
Form 4
Avnur Zafrira
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-06-15+40,000→ 40,000 totalExercise: $23.27Exp: 2028-06-15→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]One half (1/2) of the shares underlying the option shall vest on June 15, 2019 (the "Cliff Vesting Date"), the remainder of the grant shall vest in equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date.